# NOREPINEPHRINE BITARTRATE
> **ANDA216272** · Abbreviated New Drug Application (Generic) · Sponsor: NEPHRON · Approved 2026-06-11
## Drug
- **FDA Application Number:** ANDA216272
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NOREPINEPHRINE BITARTRATE
- **Generic name:** Norepinephrine Bitartrate
- **Active ingredients:** NOREPINEPHRINE BITARTRATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** NEPHRON
- **First approval:** 2026-06-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216272)
---
*MORVS · CC0 1.0*